神経認知評価とリハビリテーションの市場規模、シェア、動向分析レポート:コンポーネント別(神経認知評価テスト、神経リハビリテーション療法)、プロバイダー別(リハビリセンター、病院、クリニック)、地域別、セグメント別予測、2024年~2030年Neurocognitive Assessment And Rehabilitation Market Size, Share & Trends Analysis Report By Component (Neurocognitive Assessment Testing, Neurorehabilitation Therapy), By Providers (Rehab Centers, Hospital And Clinics), By Region, And Segment Forecasts, 2024 - 2030 神経認知評価とリハビリテーション市場の成長と動向 Grand View Research社の最新レポートによると、世界の神経認知評価とリハビリテーション市場は2030年までに246億ドルに達すると予測され、2024年から2030... もっと見る
本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。
サマリー神経認知評価とリハビリテーション市場の成長と動向Grand View Research社の最新レポートによると、世界の神経認知評価とリハビリテーション市場は2030年までに246億ドルに達すると予測され、2024年から2030年までのCAGRは8.67%で拡大すると予測されている。同市場の成長の背景には、世界的な認知症患者の増加がある。世界人口の増加と、それに伴う認知症患者の増加に伴い、認知症の状態を管理し、認知機能をできるだけ長く維持するための効果的な神経認知評価とリハビリテーションの必要性が高まっている。国連の世界人口見通し報告書によると、2050年までに世界全体で65歳以上の人口は6人に1人(16%)となり、2019年の11人に1人(9%)から増加する。 また、認知症は世界的に主要な神経疾患のひとつになると予想されている。WHOによると、世界で約5500万人が認知症であり、その60%以上が低・中所得国に居住している。ほぼすべての国で人口に占める高齢者の割合が増加しているため、この数は2030年には7800万人、2050年には1億3900万人に増加すると予想されている。 さらに、神経障害に関連する研究活動における政府のイニシアチブの高まりは、市場の成長を促進すると予想される。例えば、英国政府は2021年11月、様々な神経変性疾患の理解と治療を改善するプロジェクトに資金を提供するため、今後5年間で4億7,000万米ドルを投資すると発表した。この疾患には、運動ニューロン疾患(MND)、パーキンソン病、認知症、レビー小体型認知症(LBD)などが含まれる。 神経認知評価とリハビリテーション市場レポートハイライト - 構成要素に基づき、市場は神経認知評価検査と神経リハビリテーション療法に分けられる。神経リハビリテーション療法分野は、神経疾患の高い有病率、老年人口の増加、神経リハビリテーション機器の技術開発により、2023年の収益シェアが62%を超え、市場を支配している。 - プロバイダー別に見ると、市場はリハビリセンター、病院・診療所、在宅ケア環境、理学療法センターに分けられる。2023年にはリハビリセンター分野が市場を支配した。これは、技術の著しい進歩により、リハビリセンターが各患者固有の要件に合わせたより個別化された治療計画を提供できるようになったためである。 - 北米が神経認知評価およびリハビリテーション市場を支配したのは、医療分野における研究開発の重視などの要因によるものである。この地域は、研究機関、医療系大学、民間企業による強固なエコシステムが構築されているため、神経認知技術の継続的なイノベーションが促進されると期待されている。 - 2023年6月、コグネティヴィティ・ニューロサイエンシズはClairvoと協業し、日本を含むアジア太平洋地域でAIを活用した脳の健康管理を強化した。この協業により、CognetivityのAIプラットフォームの導入が加速し、同地域における脳の健康に対する認識が促進されることが期待される。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Component 1.2.2. Providers 1.3. Estimates and Forecast Timeline 1.4. Research Methodology 1.5. Information Procurement 1.5.1. Purchased Database 1.5.2. GVR’s Internal Database 1.5.3. Secondary Sources 1.5.4. Primary Research 1.6. Information Analysis 1.6.1. Data Analysis Models 1.7. Market Formulation & Data Visualization 1.8. Model Details 1.8.1. Volume Price Analysis 1.9. List of Secondary Sources 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Snapshot 2.2. Segment Snapshot 2.2.1. Component Outlook 2.2.2. Providers Outlook 2.3. Competitive Landscape Snapshot Chapter 3. Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.1.1. Related/Ancillary Market Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Increasing Prevalence of Neurological Disorders 3.2.1.2. Technological Advancement 3.2.1.3. Rising Government Initiatives and Funding 3.2.2. Market Restraint Analysis 3.2.2.1. High Cost of Technologies and Services 3.2.2.2. Shortage of Trained Professionals 3.3. Business Environment Analysis 3.3.1. Industry Analysis - Porter’s Five Forces 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis Chapter 4. Component Business Analysis 4.1. Component Market Share, 2023 & 2030 4.2. Segment Dashboard 4.3. Global Neurocognitive Assessment and Rehabilitation Market by Component Outlook 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.4.1. Neurocognitive Assessment Testing 4.4.1.1. Neurocognitive Assessment Testing Market, 2018 - 2030 (USD Million) 4.4.2. Neurorehabilitation Therapy 4.4.2.1. Neurorehabilitation Therapy Market, 2018 - 2030 (USD Million) Chapter 5. Providers Business Analysis 5.1. Providers Market Share, 2023 & 2030 5.2. Segment Dashboard 5.3. Global Neurocognitive Assessment and Rehabilitation Market by Providers Outlook 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.4.1. Rehab Centers 5.4.1.1. Rehab Centers Market, 2018 - 2030 (USD Million) 5.4.2. Hospital and Clinics 5.4.2.1. Hospital and Clinics Market, 2018 - 2030 (USD Million) 5.4.3. Homecare Settings 5.4.3.1. Homecare Settings Market, 2018 - 2030 (USD Million) 5.4.4. Physiotherapy Centers 5.4.4.1. Physiotherapy Centers Market, 2018 - 2030 (USD Million) Chapter 6. Regional Business Analysis 6.1. Regional Market Share Analysis, 2023 & 2030 6.2. Global Regional Market Snapshot 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030: 6.4. North America 6.4.1. North America Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.4.2. U.S. 6.4.2.1. Target Population Analysis 6.4.2.2. Regulatory Landscape 6.4.2.3. Competitive Insights 6.4.2.4. U.S. Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.4.3. Canada 6.4.3.1. Target Population Analysis 6.4.3.2. Regulatory Landscape 6.4.3.3. Competitive Insights 6.4.3.4. Canada Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5. Europe 6.5.1. Europe Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.2. Germany 6.5.2.1. Target Population Analysis 6.5.2.2. Regulatory Landscape 6.5.2.3. Competitive Insights 6.5.2.4. Germany Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.3. UK 6.5.3.1. Target Population Analysis 6.5.3.2. Regulatory Landscape 6.5.3.3. Competitive Insights 6.5.3.4. UK Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.4. France 6.5.4.1. Target Population Analysis 6.5.4.2. Regulatory Landscape 6.5.4.3. Competitive Insights 6.5.4.4. France Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.5. Italy 6.5.5.1. Target Population Analysis 6.5.5.2. Regulatory Landscape 6.5.5.3. Competitive Insights 6.5.5.4. Italy Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.6. Spain 6.5.6.1. Target Population Analysis 6.5.6.2. Regulatory Landscape 6.5.6.3. Competitive Insights 6.5.6.4. Spain Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.7. Denmark 6.5.7.1. Target Population Analysis 6.5.7.2. Regulatory Landscape 6.5.7.3. Competitive Insights 6.5.7.4. Denmark Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.8. Sweden 6.5.8.1. Target Population Analysis 6.5.8.2. Regulatory Landscape 6.5.8.3. Competitive Insights 6.5.8.4. Sweden Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.9. Norway 6.5.9.1. Target Population Analysis 6.5.9.2. Regulatory Landscape 6.5.9.3. Competitive Insights 6.5.9.4. Norway Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6. Asia Pacific 6.2.1. Asia Pacific Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.2. Japan 6.6.2.1. Target Population Analysis 6.6.2.2. Regulatory Landscape 6.6.2.3. Competitive Insights 6.6.2.4. Japan Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.3. China 6.6.3.1. Target Population Analysis 6.6.3.2. Regulatory Landscape 6.6.3.3. Competitive Insights 6.6.3.4. China Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.4. India 6.6.4.1. Target Population Analysis 6.6.4.2. Regulatory Landscape 6.6.4.3. Competitive Insights 6.6.4.4. India Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.5. South Korea 6.6.5.1. Target Population Analysis 6.6.5.2. Regulatory Landscape 6.6.5.3. Competitive Insights 6.6.5.4. South Korea Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.6. Australia 6.6.6.1. Target Population Analysis 6.6.6.2. Regulatory Landscape 6.6.6.3. Competitive Insights 6.6.6.4. Australia Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.7. Thailand 6.6.7.1. Target Population Analysis 6.6.7.2. Regulatory Landscape 6.6.7.3. Competitive Insights 6.6.7.4. Thailand Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.7. Latin America 6.7.1. Latin America Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.7.2. Brazil 6.7.2.1. Target Population Analysis 6.7.2.2. Regulatory Landscape 6.7.2.3. Competitive Insights 6.7.2.4. Brazil Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.7.3. Mexico 6.7.3.1. Target Population Analysis 6.7.3.2. Regulatory Landscape 6.7.3.3. Competitive Insights 6.7.3.4. Mexico Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.7.4. Argentina 6.7.4.1. Target Population Analysis 6.7.4.2. Regulatory Landscape 6.7.4.3. Competitive Insights 6.7.4.4. Argentina Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.8. MEA 6.8.1. MEA Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.8.2. South Africa 6.8.2.1. Target Population Analysis 6.8.2.2. Regulatory Landscape 6.8.2.3. Competitive Insights 6.8.2.4. South Africa Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.8.3. Saudi Arabia 6.8.3.1. Target Population Analysis 6.8.3.2. Regulatory Landscape 6.8.3.3. Competitive Insights 6.8.3.4. Saudi Arabia Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.8.4. UAE 6.8.4.1. Target Population Analysis 6.8.4.2. Regulatory Landscape 6.8.4.3. Competitive Insights 6.8.4.4. UAE Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.8.5. Kuwait 6.8.5.1. Target Population Analysis 6.8.5.2. Regulatory Landscape 6.8.5.3. Competitive Insights 6.8.5.4. Kuwait Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) Chapter 7. Competitive Landscape 7.1. Company Categorization 7.2. Company Market Position Analysis 7.3. Strategy Mapping 7.3.1. Expansion 7.3.2. Partnership 7.3.3. Collaborations 7.3.4. Others 7.4. Company Profiles/Listing 7.4.1. Cambridge Cognition Ltd 7.4.1.1. Overview 7.4.1.2. Financial Performance 7.4.1.3. Service Benchmarking 7.4.1.4. Strategic Initiatives 7.4.2. CogniFit Inc 7.4.2.1. Overview 7.4.2.2. Financial Performance 7.4.2.3. Service Benchmarking 7.4.2.4. Strategic Initiatives 7.4.3. Cogstate Ltd 7.4.3.1. Overview 7.4.3.2. Financial Performance 7.4.3.3. Service Benchmarking 7.4.3.4. Strategic Initiatives 7.4.4. CNS Vital Signs, LLC 7.4.4.1. Overview 7.4.4.2. Financial Performance 7.4.4.3. Service Benchmarking 7.4.4.4. Strategic Initiatives 7.4.5. Posit Science 7.4.5.1. Overview 7.4.5.2. Financial Performance 7.4.5.3. Service Benchmarking 7.4.5.4. Strategic Initiatives 7.4.6. HAPPYneuron 7.4.6.1. Overview 7.4.6.2. Financial Performance 7.4.6.3. Service Benchmarking 7.4.6.4. Strategic Initiatives 7.4.7. Constant Therapy Health 7.4.7.1. Overview 7.4.7.2. Financial Performance 7.4.7.3. Service Benchmarking 7.4.7.4. Strategic Initiatives 7.4.8. Neural Assembly Int AB 7.4.8.1. Overview 7.4.8.2. Financial Performance 7.4.8.3. Service Benchmarking 7.4.8.4. Strategic Initiatives 7.4.9. Lumos Labs 7.4.9.1. Overview 7.4.9.2. Financial Performance 7.4.9.3. Service Benchmarking 7.4.9.4. Strategic Initiatives 7.4.10. Cognetivity Neurosciences 7.4.10.1. Overview 7.4.10.2. Financial Performance 7.4.10.3. Service Benchmarking 7.4.10.4. Strategic Initiatives 7.4.11. SCHUHFRIED GmbH 7.4.11.1. Overview 7.4.11.2. Financial Performance 7.4.11.3. Service Benchmarking 7.4.11.4. Strategic Initiatives 7.4.12. NeuronUp 7.4.12.1. Overview 7.4.12.2. Financial Performance 7.4.12.3. Service Benchmarking 7.4.12.4. Strategic Initiatives 7.4.13. BrainCheck, Inc. 7.4.13.1. Overview 7.4.13.2. Financial Performance 7.4.13.3. Service Benchmarking 7.4.13.4. Strategic Initiatives
SummaryNeurocognitive Assessment And Rehabilitation Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Component 1.2.2. Providers 1.3. Estimates and Forecast Timeline 1.4. Research Methodology 1.5. Information Procurement 1.5.1. Purchased Database 1.5.2. GVR’s Internal Database 1.5.3. Secondary Sources 1.5.4. Primary Research 1.6. Information Analysis 1.6.1. Data Analysis Models 1.7. Market Formulation & Data Visualization 1.8. Model Details 1.8.1. Volume Price Analysis 1.9. List of Secondary Sources 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Snapshot 2.2. Segment Snapshot 2.2.1. Component Outlook 2.2.2. Providers Outlook 2.3. Competitive Landscape Snapshot Chapter 3. Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.1.1. Related/Ancillary Market Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Increasing Prevalence of Neurological Disorders 3.2.1.2. Technological Advancement 3.2.1.3. Rising Government Initiatives and Funding 3.2.2. Market Restraint Analysis 3.2.2.1. High Cost of Technologies and Services 3.2.2.2. Shortage of Trained Professionals 3.3. Business Environment Analysis 3.3.1. Industry Analysis - Porter’s Five Forces 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis Chapter 4. Component Business Analysis 4.1. Component Market Share, 2023 & 2030 4.2. Segment Dashboard 4.3. Global Neurocognitive Assessment and Rehabilitation Market by Component Outlook 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.4.1. Neurocognitive Assessment Testing 4.4.1.1. Neurocognitive Assessment Testing Market, 2018 - 2030 (USD Million) 4.4.2. Neurorehabilitation Therapy 4.4.2.1. Neurorehabilitation Therapy Market, 2018 - 2030 (USD Million) Chapter 5. Providers Business Analysis 5.1. Providers Market Share, 2023 & 2030 5.2. Segment Dashboard 5.3. Global Neurocognitive Assessment and Rehabilitation Market by Providers Outlook 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.4.1. Rehab Centers 5.4.1.1. Rehab Centers Market, 2018 - 2030 (USD Million) 5.4.2. Hospital and Clinics 5.4.2.1. Hospital and Clinics Market, 2018 - 2030 (USD Million) 5.4.3. Homecare Settings 5.4.3.1. Homecare Settings Market, 2018 - 2030 (USD Million) 5.4.4. Physiotherapy Centers 5.4.4.1. Physiotherapy Centers Market, 2018 - 2030 (USD Million) Chapter 6. Regional Business Analysis 6.1. Regional Market Share Analysis, 2023 & 2030 6.2. Global Regional Market Snapshot 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030: 6.4. North America 6.4.1. North America Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.4.2. U.S. 6.4.2.1. Target Population Analysis 6.4.2.2. Regulatory Landscape 6.4.2.3. Competitive Insights 6.4.2.4. U.S. Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.4.3. Canada 6.4.3.1. Target Population Analysis 6.4.3.2. Regulatory Landscape 6.4.3.3. Competitive Insights 6.4.3.4. Canada Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5. Europe 6.5.1. Europe Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.2. Germany 6.5.2.1. Target Population Analysis 6.5.2.2. Regulatory Landscape 6.5.2.3. Competitive Insights 6.5.2.4. Germany Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.3. UK 6.5.3.1. Target Population Analysis 6.5.3.2. Regulatory Landscape 6.5.3.3. Competitive Insights 6.5.3.4. UK Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.4. France 6.5.4.1. Target Population Analysis 6.5.4.2. Regulatory Landscape 6.5.4.3. Competitive Insights 6.5.4.4. France Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.5. Italy 6.5.5.1. Target Population Analysis 6.5.5.2. Regulatory Landscape 6.5.5.3. Competitive Insights 6.5.5.4. Italy Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.6. Spain 6.5.6.1. Target Population Analysis 6.5.6.2. Regulatory Landscape 6.5.6.3. Competitive Insights 6.5.6.4. Spain Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.7. Denmark 6.5.7.1. Target Population Analysis 6.5.7.2. Regulatory Landscape 6.5.7.3. Competitive Insights 6.5.7.4. Denmark Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.8. Sweden 6.5.8.1. Target Population Analysis 6.5.8.2. Regulatory Landscape 6.5.8.3. Competitive Insights 6.5.8.4. Sweden Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.5.9. Norway 6.5.9.1. Target Population Analysis 6.5.9.2. Regulatory Landscape 6.5.9.3. Competitive Insights 6.5.9.4. Norway Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6. Asia Pacific 6.2.1. Asia Pacific Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.2. Japan 6.6.2.1. Target Population Analysis 6.6.2.2. Regulatory Landscape 6.6.2.3. Competitive Insights 6.6.2.4. Japan Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.3. China 6.6.3.1. Target Population Analysis 6.6.3.2. Regulatory Landscape 6.6.3.3. Competitive Insights 6.6.3.4. China Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.4. India 6.6.4.1. Target Population Analysis 6.6.4.2. Regulatory Landscape 6.6.4.3. Competitive Insights 6.6.4.4. India Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.5. South Korea 6.6.5.1. Target Population Analysis 6.6.5.2. Regulatory Landscape 6.6.5.3. Competitive Insights 6.6.5.4. South Korea Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.6. Australia 6.6.6.1. Target Population Analysis 6.6.6.2. Regulatory Landscape 6.6.6.3. Competitive Insights 6.6.6.4. Australia Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.6.7. Thailand 6.6.7.1. Target Population Analysis 6.6.7.2. Regulatory Landscape 6.6.7.3. Competitive Insights 6.6.7.4. Thailand Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.7. Latin America 6.7.1. Latin America Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.7.2. Brazil 6.7.2.1. Target Population Analysis 6.7.2.2. Regulatory Landscape 6.7.2.3. Competitive Insights 6.7.2.4. Brazil Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.7.3. Mexico 6.7.3.1. Target Population Analysis 6.7.3.2. Regulatory Landscape 6.7.3.3. Competitive Insights 6.7.3.4. Mexico Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.7.4. Argentina 6.7.4.1. Target Population Analysis 6.7.4.2. Regulatory Landscape 6.7.4.3. Competitive Insights 6.7.4.4. Argentina Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.8. MEA 6.8.1. MEA Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.8.2. South Africa 6.8.2.1. Target Population Analysis 6.8.2.2. Regulatory Landscape 6.8.2.3. Competitive Insights 6.8.2.4. South Africa Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.8.3. Saudi Arabia 6.8.3.1. Target Population Analysis 6.8.3.2. Regulatory Landscape 6.8.3.3. Competitive Insights 6.8.3.4. Saudi Arabia Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.8.4. UAE 6.8.4.1. Target Population Analysis 6.8.4.2. Regulatory Landscape 6.8.4.3. Competitive Insights 6.8.4.4. UAE Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) 6.8.5. Kuwait 6.8.5.1. Target Population Analysis 6.8.5.2. Regulatory Landscape 6.8.5.3. Competitive Insights 6.8.5.4. Kuwait Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million) Chapter 7. Competitive Landscape 7.1. Company Categorization 7.2. Company Market Position Analysis 7.3. Strategy Mapping 7.3.1. Expansion 7.3.2. Partnership 7.3.3. Collaborations 7.3.4. Others 7.4. Company Profiles/Listing 7.4.1. Cambridge Cognition Ltd 7.4.1.1. Overview 7.4.1.2. Financial Performance 7.4.1.3. Service Benchmarking 7.4.1.4. Strategic Initiatives 7.4.2. CogniFit Inc 7.4.2.1. Overview 7.4.2.2. Financial Performance 7.4.2.3. Service Benchmarking 7.4.2.4. Strategic Initiatives 7.4.3. Cogstate Ltd 7.4.3.1. Overview 7.4.3.2. Financial Performance 7.4.3.3. Service Benchmarking 7.4.3.4. Strategic Initiatives 7.4.4. CNS Vital Signs, LLC 7.4.4.1. Overview 7.4.4.2. Financial Performance 7.4.4.3. Service Benchmarking 7.4.4.4. Strategic Initiatives 7.4.5. Posit Science 7.4.5.1. Overview 7.4.5.2. Financial Performance 7.4.5.3. Service Benchmarking 7.4.5.4. Strategic Initiatives 7.4.6. HAPPYneuron 7.4.6.1. Overview 7.4.6.2. Financial Performance 7.4.6.3. Service Benchmarking 7.4.6.4. Strategic Initiatives 7.4.7. Constant Therapy Health 7.4.7.1. Overview 7.4.7.2. Financial Performance 7.4.7.3. Service Benchmarking 7.4.7.4. Strategic Initiatives 7.4.8. Neural Assembly Int AB 7.4.8.1. Overview 7.4.8.2. Financial Performance 7.4.8.3. Service Benchmarking 7.4.8.4. Strategic Initiatives 7.4.9. Lumos Labs 7.4.9.1. Overview 7.4.9.2. Financial Performance 7.4.9.3. Service Benchmarking 7.4.9.4. Strategic Initiatives 7.4.10. Cognetivity Neurosciences 7.4.10.1. Overview 7.4.10.2. Financial Performance 7.4.10.3. Service Benchmarking 7.4.10.4. Strategic Initiatives 7.4.11. SCHUHFRIED GmbH 7.4.11.1. Overview 7.4.11.2. Financial Performance 7.4.11.3. Service Benchmarking 7.4.11.4. Strategic Initiatives 7.4.12. NeuronUp 7.4.12.1. Overview 7.4.12.2. Financial Performance 7.4.12.3. Service Benchmarking 7.4.12.4. Strategic Initiatives 7.4.13. BrainCheck, Inc. 7.4.13.1. Overview 7.4.13.2. Financial Performance 7.4.13.3. Service Benchmarking 7.4.13.4. Strategic Initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Grand View Research社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD(assessment)の最新刊レポートよくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |